Ginseng can treat and prevent influenza and respiratory virus

Image
Press Trust of India Washington
Last Updated : Apr 22 2014 | 3:24 PM IST
Ginseng, a well-known herbal medicine, can help treat and prevent influenza and respiratory syncytial virus (RSV) that infects the lungs and breathing passages, according to new research.
Ginseng has been reported to have anticancer, anti-inflammatory and immune modifying abilities, researchers said.
Sang-Moo Kang, a scientist in Georgia State University investigated whether red ginseng extract has preventive effects on influenza A virus infection.
He found that red ginseng extract improves the survival of human lung epithelial cells infected with influenza virus. Also, treatment with red ginseng extract reduced the expression of genes that cause inflammation.
After infection with influenza A virus, mice that were orally administered ginseng over a long time showed multiple immune modifying effects, such as stimulated antiviral production of proteins important in immune response and fewer inflammatory cells in their bronchial walls.
The study indicates the beneficial effects of red ginseng extract in preventing influenza A virus infections could result from immune modifying capabilities of ginseng.
In another study, Kang investigated whether Korean red ginseng extract has antiviral effects, or the ability to treat RSV infection.
Kang found Korean red ginseng extract improved the survival of human lung epithelial cells against RSV infection and inhibited the virus from replicating, or multiplying, in the body.
In addition, treatment with Korean red ginseng extract suppressed the expression of RSV-induced inflammatory genes and the formation of chemically reactive molecules containing oxygen, which play a role in virus-induced epithelial damage in RSV, researchers said.
Also, mice that were orally administered Korean red ginseng extract had lower viral levels after infection with RSV. The results suggest that Korean red ginseng extract has antiviral activity against RSV infection.
The findings appear in the journal Nutrients and the International Journal of Molecular Medicine.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 22 2014 | 3:24 PM IST

Next Story